Kim, S. T., Choi, Y. J., Park, K. H., Oh, S. C., Seo, J. H., Shin, S. W., . . . Kim, Y. H. (2011). Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Chemotherapy (Basel), 57(2), 108-114. https://doi.org/10.1159/000321490
Chicago Style (17th ed.) CitationKim, Seung Tae, Yoon Ji Choi, Kyong Hwa Park, Sang Cheul Oh, Jae Hong Seo, Sang Won Shin, Jun Suk Kim, and Yeul Hong Kim. "Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors." Chemotherapy (Basel) 57, no. 2 (2011): 108-114. https://doi.org/10.1159/000321490.
MLA (9th ed.) CitationKim, Seung Tae, et al. "Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors." Chemotherapy (Basel), vol. 57, no. 2, 2011, pp. 108-114, https://doi.org/10.1159/000321490.